Search clinical trials for: [64Cu]FBP8

Total 68 results

Peter Caravan
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

PET Fibrin Imaging of DVT and PE

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Positron Emission Tomography (PET) Imaging of Thrombosis

COVID-19 | Cancer | Thrombosis | Atrial Fibrillation

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Assess Fibrin in Brains With AD/ADRD

Alzheimer Disease | Dementia of Alzheimer Type

United States
Clarity Pharmaceuticals Ltd

Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) (SECuRE)

Prostatic Neoplasms, Castration-Resistant

United States
Clarity Pharmaceuticals Ltd

Recruiting

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (COMBAT)

Prostatic Neoplasms | Castration-Resistant

United States
Clarity Pharmaceuticals Ltd

Recruiting

A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)

Neuroendocrine Tumors

Australia
Clarity Pharmaceuticals Ltd

Completed

An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours

Neuroendocrine Tumors
Institut Cancerologie de l'Ouest
Fondation ARC

Active, not recruiting

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Rectal Cancer

France
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) (CUPID)

Metastatic Prostate Cancer

Australia
Peking Union Medical College Hospital

Recruiting

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

Colorectal Cancer

China
Luke Nordquist, MD
Clarity Pharmaceuticals

Not yet recruiting

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Prostate Cancer

United States
Washington University School of Medicine
National Institutes of Health (NIH); National Institute for Biomedical Imaging...

Terminated

Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer

Head and Neck Cancer

United States
Chinese PLA General Hospital
Sinotau Pharmaceutical Group

Completed

First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Malignant Solid Tumors

China
Massachusetts General Hospital
National Cancer Institute (NCI)

Recruiting

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Lung Cancer | Pancreas Cancer | Radiation Fibrosis | Radiation Induced Lung Injury

United States
Clarity Pharmaceuticals Ltd

Completed

Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™

Meningioma

Australia
The First Affiliated Hospital of Guangzhou Medical...
Sinotau Pharmaceutical Group

Completed

Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Malignant Solid Tumors

China
Clarity Pharmaceuticals Ltd

Completed

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) (COBRA)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Clarity Pharmaceuticals Ltd

Completed

Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (PROPELLER)

Prostatic Neoplasms

Australia
Clarity Pharmaceuticals Ltd

Recruiting

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Neuroblastoma | Refractory Neuroblastoma | Relapsed Neuroblastoma

United States
Clarity Pharmaceuticals Ltd

Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy (CLARIFY)

Prostatic Neoplasms | Prostate Cancer

United States
Clarity Pharmaceuticals Ltd

Active, not recruiting

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) (SABRE)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI); Cedars-Sinai Medical Center and other collaborators

Recruiting

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Carotid Atherosclerosis | Asymptomatic Carotid Artery Stenosis | Carotid Artery Atheroma

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Pulmonary Fibrosis | Lung Cancer

United States
Rigshospitalet, Denmark

Recruiting

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis (CuDOSIS)

Cardiac Sarcoidosis

Denmark
Washington University School of Medicine

Recruiting

Evaluation of CCR2 in Patients Post Myocardial Infarction

Heart Diseases

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Recruiting

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Pancreatic Ductal Adenocarcinoma

United States
Radiomedix, Inc.

Completed

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

Neuroendocrine Tumors

United States
Curium US LLC

Completed

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

Metastasis From Malignant Tumor of Prostate (Disorder)

United States
Rahul Aggarwal
National Cancer Institute (NCI); U.S. Army Medical Research Acquisition Activity

Recruiting

64Cu-GRIP B in Patients With Advanced Malignancies

Prostate Cancer | Advanced Solid Tumor | Renal Cancer | Urethral Cancer | Solid Tumor, Adult | Metastatic Castration-resistant Prostate Cancer

United States
Fujifilm Medical Systems USA, Inc.
International HealthCare, LLC

Completed

Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing

Breast Cancer

United States
Brigham and Women's Hospital

Recruiting

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

Cardiac Amyloidosis

United States
Lantheus Medical Imaging

Not yet recruiting

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer (PHANTOM)

Sarcoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Metastatic Sarcoma
Washington University School of Medicine

Withdrawn

64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab

Carcinoma, Non-Small-Cell Lung
Rigshospitalet, Denmark

Completed

Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

Breast Cancer | Prostate Cancer | Urinary Bladder Cancer

Denmark
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
Memorial Sloan Kettering Cancer Center

Recruiting

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Cancer | Metastatic Pancreatic Ductal Adenocarcinoma | Primary Pancreatic Ductal Adenocarcinoma

United States
American College of Radiology
National Cancer Institute (NCI); American College of Radiology Imaging Network

Terminated

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (ACRIN6682)

Cervical Cancer

United States
Washington University School of Medicine

Recruiting

PET Detection of CCR2 in Human Atherosclerosis

Carotid Atherosclerosis

United States
Emil Loldrup Fosbol

Recruiting

64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

Endocarditis | Endocarditis;Chronic | Endocarditis Acute

Denmark
Thomas Hope
Clovis Oncology, Inc.

Recruiting

Imaging of Solid Tumors Using FAP-2286

Metastatic Cancer | Solid Tumors, Adult

United States
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
Federal University of São Paulo

Unknown

Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma

Pediatric Glaucoma

Brazil
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Elucida Oncology

Recruiting

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Prostate Cancer

United States
Washington University School of Medicine

Terminated

CCR2 AAA Pilot Study

Abdominal Aortic Aneurysm (AAA)

United States
Washington University School of Medicine

Terminated

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

Sarcoma | Lymphoma | Carcinoma

United States
Jeffrey L. Lacy
University of Wisconsin, Madison

Completed

Renal Blood Flow Measurement With Positron Emission Tomography (PET)

Renal Failure | Renal Artery Stenosis

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation

Metastatic Malignant Solid Neoplasm

United States
Washington University School of Medicine

Recruiting

64Cu-LLP2A for Imaging Multiple Myeloma

Multiple Myeloma

United States
Bristol-Myers Squibb

Terminated

Effectiveness of KOS-862 in the Treatment of Lung Cancer

Lung Cancer
Jiangsu Province Centers for Disease Control and...
Bejing Vigoo Biological Co., LTD

Completed

A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants

Safety | Immunogenicity

China

Search clinical trials for: [64Cu]FBP8

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations